Abstract

ObjectiveTo evaluate the influence of the mitochondrial DNA (mtDNA) haplogroups in the risk of incident knee osteoarthritis (OA) and to explain the functional consequences of this association to identify potential...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
SAT0005 A Meta-Analysis and A Functional Study with Transmitochondrial Cybrids Confirm The Role of The Mtdna Haplogroups in The Development of Incident Knee Osteoarthritis. Data from Check and Oai
S Relaño ... A Soto-Hermida
Annals of the Rheumatic Diseases | VOL. 75
S Relaño, et. al.S Relaño ... A Soto-Hermida
01 Jun 2016
Risk of Knee Osteoarthritis With Obesity, Sarcopenic Obesity, and Sarcopenia.
Jingbo Niu ... Roger A Fielding
Arthritis & rheumatology (Hoboken, N.J.) | VOL. 71
Jingbo Niu, et. al.Jingbo Niu ... Roger A Fielding
04 Jan 2019
Association between nighttime sleep duration and quality with knee osteoarthritis in middle-aged and older Chinese: A longitudinal cohort study
Mingyang Li ... Limin Wu
Archives of Gerontology and Geriatrics | VOL. 118
Mingyang Li, et. al.Mingyang Li ... Limin Wu
23 Nov 2023
Occupation and risk of knee osteoarthritis and knee replacement: A longitudinal, multiple-cohort study
Maria T Sanchez-Santos ... David J Hunter
Seminars in Arthritis and Rheumatism | VOL. 50
Maria T Sanchez-Santos, et. al.Maria T Sanchez-Santos ... David J Hunter
08 Aug 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers